Healius Limited (HLS) To Go Ex-Dividend on May 8th

Healius Limited (ASX:HLS) declared a interim dividend on Tuesday, May 6th, MarketIndexAU Dividends reports. Investors of record on Thursday, May 22nd will be paid a dividend of 0.413 per share on Thursday, May 22nd. This represents a yield of 26.14%. The ex-dividend date is Thursday, May 8th. This is a 313.0% increase from Healius’s previous interim dividend of $0.10.

Healius Price Performance

The company has a debt-to-equity ratio of 153.54, a current ratio of 0.50 and a quick ratio of 0.47. The company has a market capitalization of $1.01 billion, a P/E ratio of -2.54, a price-to-earnings-growth ratio of -0.94 and a beta of 0.73.

About Healius

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands.